AssuredPartners Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.05M Sell
8,728
-3,604
-29% -$416K 0.11% 186
2025
Q4
$1.3M Buy
12,332
+7,701
+166% +$723K 0.19% 121
2025
Q3
$389K Sell
4,631
-170
-4% -$14K 0.09% 173
2025
Q2
$380K Sell
4,801
-2,620
-35% -$208K 0.09% 162
2025
Q1
$666K Sell
7,421
-471
-6% -$44K 0.13% 168
2024
Q4
$785K Buy
+7,892
New +$814K 0.15% 143

Other funds holding MRK

AssuredPartners Investment Advisors's MRK Position: Q1 2026 in Review

AssuredPartners Investment Advisors reduced its Merck (MRK) stake by 29% in Q1 2026, selling an estimated $416K and leaving 8,728 shares worth $1.05M. The position accounts for 0.11% of the portfolio, ranked #186.

AssuredPartners Investment Advisors first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.3M in Q4 2025. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • AssuredPartners Investment Advisors held 8,728 shares of Merck worth $1.05M as of Q1 2026.
  • AssuredPartners Investment Advisors sold 3,604 Merck shares in Q1 2026, an estimated $416K.
  • Merck made up 0.11% of AssuredPartners Investment Advisors's portfolio in Q1 2026, its #186 holding.
  • AssuredPartners Investment Advisors first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • AssuredPartners Investment Advisors's Merck position peaked at $1.3M in Q4 2025.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on AssuredPartners Investment Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.